Pathogenetic and immunotherapeutic significance of a cutaneous burn toxin in experimental pseudomonas infection
Postel, J.; Allgöwer, M.; Burkhart, F.; Müller, W.; Städtler, K.; Schoenenberger, G.A.
Helvetica Chirurgica Acta 41(1-2): 7-11
1974
ISSN/ISBN: 0018-0181 PMID: 4436111 Document Number: 75664
Document emailed within 1 workday
Related Documents
Okada, K.; Kawaharajo, K.; Kasai, T.; Homma, J.Y. 1980: Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection Japanese Journal of Experimental Medicine 50(1): 53-61Thomas, M.Z.; Southern, P.M. 1974: Antimicrobial therapy in experimental pseudomonas infection Texas Reports on Biology and Medicine 32(2): 569-577
Meitert, E.; Petrovici, M.; Sima, F.; Costache, G.; Savulian, C. 1987: Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa Archives Roumaines de Pathologie Experimentales et de Microbiologie 46(1): 17-26
Litovchenko, P.P. 1980: Effect of chlorhexidine bigluconate on the development of experimental Pseudomonas aeruginosa eye infection in rabbits Mikrobiolohichnyi Zhurnal 42(1): 103-108
Shcherbakova, E.G.; Medvedeva, M.M.; Rastunova, G.A.; Sobolev, V.R. 1975: Action of gentamicin, tobramycin and their combinations with prodigiozan in an experimental infection caused by Pseudomonas aeruginosa Antibiotiki 20(12): 1112-1115
Mai, K.; Eckhardt, R. 1972: Treatment of experimental Pseudomonas aeruginosa infection with carbenicillin and antiserum. Dose-effect relations Arzneimittel-Forschung 22(4): 809-813
Salageanu, A.; Ceacareanu, B.; Popescu, D.; Istrate, N.; Szegli, G. 1998: Experimental studies on bacterial product CANTASTIM derived from Pseudomonas aeruginosa. II. Protective effect in Salmonella typhimurium infection Roumanian Archives of Microbiology and Immunology 56(1-2): 17-26
Mizuno, H.; Ashikawa, K. 1991: Pseudomonas multicomponent vaccine in major burn patients Nihon Rinsho. Japanese Journal of Clinical Medicine 49(10): 2425-2430
Cai, J.-h.; Chai, J.-k.; Shen, C.-a.; Yin, H.-n.; Zhou, X.-f.; Lu, W.; Hu, Q.-g.; Chi, Y.-f.; Ma, L.; Deng, H.-p.; Zhang, X.-b.; Sun, T.-j.; Han, Y.-f. 2010: Early changes in serum neutrophil elastase in rats with burn, blast injury or combined burn-blast injury and its significance Zhonghua Yi Xue Za Zhi 90(24): 1707-1710
Schölmerich, J.; Kremer, B.; Schmidt, K.; Schoenenberger, G.A.; Hermawan, S. 1977: Metabolism and morphology of the rat liver following skin burns and administration of a "burn toxin". a combination study method Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 519-523
Kalantar, E.; Taherzadeh, S.; Ghadimi, T.; Soheili, F.; Salimizand, H.; Hedayatnejad, A. 2012: Pseudomonas aeruginosa, an emerging pathogen among burn patients in Kurdistan Province, Iran Southeast Asian Journal of Tropical Medicine and Public Health 43(3): 712-717
Cryz, S.J.; Lang, A.; Rüdeberg, A.; Wedgwood, J.; Que, J.U.; Fürer, E.; Schaad, U. 1997: Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine Behring Institute Mitteilungen 1997(98): 345-349
Cryz, S.J.; Sadoff, J.C.; Ohman, D.; Fürer, E. 1988: Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin a conjugate vaccine Journal of Laboratory and Clinical Medicine 111(6): 701-707
Shigeta, S.; Goto, S.; Ishida, N. 1971: Pseudomonas aeruginosa infection in the hospital environment. 2. Pigment production and serotype of Pseudomonas aeruginosa isolated from clinical specimens Rinsho Byori. Japanese Journal of Clinical Pathology 19(1): 77-80
Vetkova, L.G.; Zaĭtsev, L.G.; Khasman, E.L.; Radkevich, S.A.; Moroz, A.F. 1986: Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 14-18
Wang, Q.C.; Pai, L.H.; Debinski, W.; FitzGerald, D.J.; Pastan, I. 1993: Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin Cancer Research 53(19): 4588-4594
Dhawan, A.; Dhawan, S.; Vitarella, D. 2018: The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: a Review Journal of Drugs in Dermatology: Jdd 17(9): 956-958
Timchenko, N.F.; Somov, G.P. 1986: Pathogenetic significance of the psychrophilia of Yersinia pseudotuberculosis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 34-38
Elvira, J.; López-Suárez, A.; Clavo, A.; Piña, J.M.; Segura, E.; Pérez-Guzmán, E.; Girón, J.A. 1998: Infection by Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Descriptive study of 35 cases Enfermedades Infecciosas y Microbiologia Clinica 16(7): 322-327
Haustein, U.F.; Barthelmes, H.; Sönnichsen, N. 1973: The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies Acta Biologica et Medica Germanica 30(2): 265-273